ACHL

Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer-and Chemotherapy-Induced Anemia

Overview / Abstract:	This quick, comprehensive video will review the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath from University of Utah Hospitals and Clinics will discusses the role of intravenous (IV) iron replacement monotherapy, including ferric carboxymaltose (FCM), recent clinical trial data supporting its benefit in treatment of CIA, and management of adverse events in patients receiving this therapy.
Expiration	Mar 25, 2023
Discipline(s)	Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME
Format	Webinar / Webcast / Video
Credits / Hours	0.25
Accreditation	ACCME
Presenters / Authors / Faculty	Jeffrey Gilreath, PharmD Clinical Professor of Pharmacy Department of Pharmacotherapy Clinical Hematology/Oncology Pharmacist University of Utah Hospitals and Clinics Salt Lake City, UT
Activity Specialities / Related Topics	Hematology, Oncology / Cancer / Radiation Therapy
Sponsors / Supporters / Grant Providers	Supported by an educational grant from American Regent, Inc.
Keywords / Search Terms	ACHL IRON CLAD, anemia, iron deficiency, chemotherapy, blood transfusion, iv iron, chemotherapy induced anemia, CIA, Jeffrey Gilreath, PharmD, CME, CE, Webcast, University of Utah Hospitals and Clinics Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map